Tradestie Institutional Equity Comparison Engine

ACHC vs SGRY โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ACHC Overall Edge

ACHC Captures Institutional Edge (2โ€“2 Pillars ยท 5โ€“5 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Acadia Healthcare Company, Inc. (ACHC) driven by superior Valuation, Options & Structure while SGRY counters with relative strength in Growth & Margin, Momentum & Technical. Fundamentally, ACHC trades at 17.0x Forward P/E with 9.8% operating margin (+5.1% YoY revenue) versus SGRY at N/M Forward P/E and 13.2% operating margin (-0.8% YoY). In options structure, ACHC sits in CONSOLIDATION (31st %ile IV; Dealer Gamma Walls on Pro) against SGRY sits in SURGE (34th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner ACHC
ACHC 17.0x vs SGRY N/M Fwd P/E
Growth & Margin Winner SGRY
Op Margin 9.8% vs 13.2% ยท YoY +5.1% vs -0.8%
Momentum & Technical Winner SGRY
1Y +141.3% vs +70.5% ยท 52W Pos 82% vs 97%
Options & Structure Winner ACHC
CONSOLIDATION (31st %ile IV) vs SURGE (34th %ile IV)
ACHC NASDAQ
Acadia Healthcare Company, Inc.
Services-Specialty Outpatient Facilities, Nec
$34.60
+0.38% 1D
Market Cap $3.2B
1M Return +8.53%
1Y Return +141.28%
Forward P/E 17.0x
Unified AI Score
33.1 / 100 SELL
Tech 15.0 Fund 36.0 Flow 59.0 Mom 36.4
SGRY NASDAQ
Surgery Partners, Inc. Common Stock
Services-General Medical & Surgical Hospitals, Nec
$26.78
+0.34% 1D
Market Cap $3.5B
1M Return +68.43%
1Y Return +70.46%
Forward P/E N/M
Unified AI Score
29.6 / 100 SELL
Tech 50.0 Fund 24.0 Flow 56.0 Mom 21.1

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ACHC +141.28% SGRY +70.46% Spread: +70.82 pp (ACHC Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period ACHC Revenue SGRY Revenue ACHC Op. Margin SGRY Op. Margin Margin Edge
FY2018 $1.90B $1.77B 31.2% 4.4% ACHC
FY2019 $2.01B $1.83B 29.2% 12.9% ACHC
FY2020 $2.09B $1.86B -32.2% 9.8% SGRY
FY2021 $2.31B $2.23B 8.2% 13.6% SGRY
FY2022 $2.61B $2.54B 10.5% 13.6% SGRY
FY2023 $2.93B $2.74B -0.7% 12.0% SGRY
FY2024 $3.15B $3.11B 8.1% 11.2% SGRY
FY2025 $3.31B $3.31B -33.3% 11.8% SGRY

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ACHC (5) vs SGRY (5)
Institutional Metric ACHC SGRY Criterion Row Winner
Market Capitalization Scale $3.2B $3.5B Larger Scale SGRY
Trailing P/E Ratio Valuation 16.9x N/M Lower Multiple ACHC
Forward P/E Ratio Valuation 17.0x N/M Lower Multiple ACHC
Revenue Growth (YoY) Growth +5.1% -0.8% Higher Growth ACHC
Operating Margin (TTM) Profitability 9.8% 13.2% Higher Margin SGRY
Net Profit Margin Profitability -33.1% -2.6% Higher Margin SGRY
Return on Equity (ROE) Capital Efficiency -40.5% 2.1% Higher ROE SGRY
52-Week Range Position Momentum 82% ($11โ€“$40) 97% ($11โ€“$27) Stronger Trend SGRY
Beta / 30D Volatility Risk Regime 1.00ฮฒ ยท 61% Vol 0.87ฮฒ ยท 166% Vol Lower Realized Risk ACHC
Unified Institutional Score Composite Signal 33.1 / 100 (SELL) 29.6 / 100 (SELL) Higher Composite ACHC

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ACHC vs SGRY Buy Guide
ACHC CONSOLIDATION
87d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 31st %ile
IV Regime Balanced (25thโ€“60th %ile)
Live ACHC Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
SGRY SURGE
5d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 34th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live SGRY Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ACHC nor SGRY registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.